Novateor Research Laboratories Ltd
Novateor Research Laboratories Ltd (NOVATEOR): company summary
The company's revenue grew 37.8% annually, but net profit remained at ₹0 crore, with a net profit margin that fell 0.2 percentage points to 2.6%.
Novateor Research Laboratories Ltd (NOVATEOR) is a micro-cap Consumer Goods company valued at ₹24 crore operating in Personal Care on the NSE and BSE.
- Recent price move
- Novateor Research Laboratories Ltd last traded at ₹39, up 4.00% on the day.
- Recent developments
- On 2026-03-31, the company reported its latest quarter results, showing revenue of ₹1 crore, flat with the prior year's quarter, but down 31.3% from the same quarter a year earlier. The company's revenue has grown at a 44.9% annual rate over the past three years and 82.3% over the past five years.
- Financial performance
- The company's revenue grew 37.8% annually, but net profit remained at ₹0 crore, with a net profit margin that fell 0.2 percentage points to 2.6%. The latest quarter saw revenue drop 31.3% year-on-year to ₹1 crore, while net profit stayed at ₹0 crore, though it rose 140.0% from the previous quarter's ₹0 crore.
- Valuation multiples
- The stock trades at 229.4 times earnings, 1.90 times book value.
- Things to watch
- The company has not reported any net profit in the latest fiscal year or the latest quarter, despite revenue growth. The net profit margin has declined, and the company's return on equity is very low at 0.9%. The stock is trading at its 52-week high, but the company's net profit remains at zero.
- Where it stands
- Novateor Research Laboratories Ltd has seen strong revenue growth, but net profit remains at zero. The stock is at its 52-week high, but the company's financials show no profitability. The most significant figure is the company's revenue, which has grown rapidly over the past five years.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (8.5) and momentum (7.5), but held back by valuation (0.0). Growth looks strong at 8.5, but that is offset by valuation at 0.0 and quality at 1.7. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Revenue compounding 82% a year
- Profit compounding 58% a year
- Low leverage — D/E 0.09
- Quality is weak (1.7/10)
- Valuation is weak (0.0/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Consumer Goods stocks · Personal Care
Explore Novateor Research Laboratories Ltd’s valuation
Free deep-dive tools · no sign-up
Novateor Research Laboratories Ltd peers in Consumer Goods
Other Consumer Goods stocks on the NSE & BSE. See the full Consumer Goods sector list.
Related tools & concepts
Value Novateor Research Laboratories Ltd with the ratios and calculators DocStoX uses in its analysis.

